Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical TrialNewsfile Corp • 02/19/26
Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear ImplantNewsfile Corp • 02/17/26
Envoy Medical Announces Closing of Up to $78.0 Million Upsized Public OfferingNewsfile Corp • 02/12/26
Envoy Medical to Present at the Small Cap Growth Virtual Investor Conference February 5GlobeNewsWire • 01/29/26
Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear ImplantNewsfile Corp • 12/18/25
Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear ImplantNewsfile Corp • 12/10/25
Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant PatientNewsfile Corp • 12/04/25
Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted BatteryNewsfile Corp • 11/20/25
Envoy Medical, Inc. (COCH) Reports Q3 Loss, Misses Revenue EstimatesZacks Investment Research • 11/10/25
Envoy Medical, Inc. (COCH) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 11/06/25
Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical TrialNewsfile Corp • 11/04/25
Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear ImplantNewsfile Corp • 10/29/25
Bears are Losing Control Over Envoy Medical, Inc. (COCH), Here's Why It's a 'Buy' NowZacks Investment Research • 10/20/25
Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNewsfile Corp • 10/09/25
Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNewsfile Corp • 10/08/25
Envoy Medical Receives FDA Approval to Expand Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month DataNewsfile Corp • 10/07/25
Envoy Medical Receives FDA Approval to Advance Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month DataNewsfile Corp • 10/07/25
Envoy Medical to Participate in the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) Conference on October 11th-14thNewsfile Corp • 10/01/25
Envoy Medical Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNewsfile Corp • 09/25/25
Envoy Medical Advances Commercialization Planning for Breakthrough Hearing Device as FDA Clinical Trial Remains On TrackNewsfile Corp • 09/24/25
Envoy Medical Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNewsfile Corp • 09/22/25